Your innovative aerosol therapy – our drug-nebulizer expertise

Your innovative aerosol therapy – our drug-nebulizer expertise

All you need to know about our partnering approach for pharmaceutical companies

Learn directly from our experts how we, as your partner, can support you in the development of your innovative aerosol therapy. The following series of short interviews answers question like: What do we offer in our so-called partner projects? When do the individual phases of such projects take place and what are they about? How do we optimize nebulizers for specific drug formulations?

The videos build on each other according to the numbering. Each video takes 3-4 minutes.

Do you have any questions? Have we aroused your interest?

Contact us

Part 5 of 5

Commercialization stage

Some interesting background information from Matthias Brosig, Director eFlow Alliance Operations, on the transition to the commercial phase and how we accompany the marketing of your drug and device product.


Part 4 of 5

Development stage

Dr. Markus Tservistas, Senior Project Leader eFlow, explains how the previous evaluation work is continued in the development stage and how we can support clinical trials and regulatory submissions.

Part 3 of 5

Optimization of eFlow Technology nebulizers

Let Dr. Benjamin Heine, Technology Platform Leader eFlow, take you to the heart of our eFlow nebulizers and give you an idea of the effort and methods used to customize them.

Part 2 of 5

Evaluation stage

Jonas Knoch, Business Development Manager eFlow, provides valuable insights into the evaluation of early drug and device combination products.

Click here to contact Jonas Knoch directly.


Part 1 of 5

PARI’s eFlow Partnering Business

Find out more from Michael Hahn, VP eFlow Partnering and Strategy, about our offering and the benefits of working with PARI.

Click here to contact Michael Hahn directly.

Contact us

Do you have any questions about our technology, partnering approach and services?

Please contact us!
eFlow-partneringpari.com


 

I have acknowledged the information regarding data processing.